Search Results 501-510 of 2118 for 查论文ai率的网站,ai人工智能网址,图片ai生成网站,免费的ai写作网站,ai绘画动漫网站,等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.wd.chat
Tzilas V, Sykes AG, Lindell RM, Yi ES, Ryu JH. Pulmonary mucosa-associated lymphoid tissue lymphoma (MALToma): Clinico-radiologic features, diagnosis, ...
About this study. The primary objectives of this study are to determine the maximum tolerated dose/recommended phase 2 dose (MTD/RP2D) of selumetinib + ...
Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.
Publications · Rosenbaum AN, Bois MC, Zhang X, Santivasi WL, Freeman WK. Primary Malignant Pericardial Mesothelioma: A Clinical Case Series Illustrating the ...
5 will be assessed by measuring the extent of tumor shrinkage. SC16LD6.5 is an antibody-drug conjugate (ADC). The antibody (SC16) targets a protein that appears ...
A multidisciplinary faculty guides research in the Mayo Clinic Alzheimer's Disease Research Center.
Mayo Clinic researcher Xiaoxi Yao, Ph.D., M.P.H., conducts health system-embedded patient-centered outcomes research and comparative effectiveness research. She ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. Aims, purpose, or objectives: To describe the clinical features along with treatment outcomes of a cohort of patients with a diagnosis of ...
Tipifarnib will be administered until disease progression then followed approximately every 12 weeks for survival until either death or 12 months after accrual ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.